Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiwa

Showing results (291-300 of 308) with videos related to

Pageof 31
Sort By:
Antiviral Research|March 28, 2022
Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variantsMikako Ueno, Naoko Iwata-Yoshikawa, Akihiro Matsunaga, et al.
Scientific Reports|September 18, 2024
The comparison of pathogenicity among SARS-CoV-2 variants in domestic catsEun-Sil Park, Yudai Kuroda, Akihiko Uda, et al.
Plos Pathogens|July 19, 2021
Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaquesTakushi Nomura, Hiroyuki Yamamoto, Masako Nishizawa, et al.
Scientific Reports|December 2, 2022
Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in miceTomoyuki Homma, Noriyo Nagata, Masayuki Hashimoto, et al.
Communications Biology|March 23, 2025
Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variantsYuki Anraku, Shunsuke Kita, Taishi Onodera, et al.
Scientific Reports|January 31, 2024
Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in miceTomoyuki Homma, Noriyo Nagata, Masayuki Hashimoto, et al.
Cell Reports. Medicine|March 2, 2022
Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8<sup>+</sup> T cell responsesHiroshi Ishii, Takushi Nomura, Hiroyuki Yamamoto, et al.
Nature Communications|November 7, 2020
Publisher Correction: TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancerLaura Garcia Perez, Jan Kempski, Heather M McGee, et al.
Nature Communications|May 27, 2020
TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancerLaura Garcia Perez, Jan Kempski, Heather M McGee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2023
Tr1 Cells Emerge and Suppress Effector Th17 Cells in GlomerulonephritisShiwa Soukou-Wargalla, Christoph Kilian, Lis N Velasquez, et al.
Pageof 31

Showing results (291-300 of 308) with videos related to

Sort By:
Pageof 31
Antiviral Research|March 28, 2022
Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variantsMikako Ueno, Naoko Iwata-Yoshikawa, Akihiro Matsunaga, et al.
Scientific Reports|September 18, 2024
The comparison of pathogenicity among SARS-CoV-2 variants in domestic catsEun-Sil Park, Yudai Kuroda, Akihiko Uda, et al.
Plos Pathogens|July 19, 2021
Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaquesTakushi Nomura, Hiroyuki Yamamoto, Masako Nishizawa, et al.
Scientific Reports|December 2, 2022
Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in miceTomoyuki Homma, Noriyo Nagata, Masayuki Hashimoto, et al.
Communications Biology|March 23, 2025
Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variantsYuki Anraku, Shunsuke Kita, Taishi Onodera, et al.
Scientific Reports|January 31, 2024
Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in miceTomoyuki Homma, Noriyo Nagata, Masayuki Hashimoto, et al.
Cell Reports. Medicine|March 2, 2022
Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8<sup>+</sup> T cell responsesHiroshi Ishii, Takushi Nomura, Hiroyuki Yamamoto, et al.
Nature Communications|November 7, 2020
Publisher Correction: TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancerLaura Garcia Perez, Jan Kempski, Heather M McGee, et al.
Nature Communications|May 27, 2020
TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancerLaura Garcia Perez, Jan Kempski, Heather M McGee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2023
Tr1 Cells Emerge and Suppress Effector Th17 Cells in GlomerulonephritisShiwa Soukou-Wargalla, Christoph Kilian, Lis N Velasquez, et al.
Pageof 31